The results, presented in Stockholm at EuroPRevent 2009, reflect what many other studies have indicated, but, says investigator Professor Haakon Meyer from the University of Oslo and Norwegian Institute of Public Health, these results provide a picture of the long-term, absolute "real life" risk.
Behind his conclusions lies a far-reaching follow-up study which began in 1974 with an invitation to every middle aged man and woman (aged 35-49) living in three counties of Norway to take part in a basic cardiovascular screening examination. The invitation had a huge response, with 91% attending for the baseline screen.
Over the next three decades deaths were recorded by linkage to the Norwegian population registry and, between 2006 and 2008, those surviving responded to a follow-up questionnaire. This allowed division of the participants according to their smoking status – never-smokers, ex-smokers, current smokers of 1-9 cigarettes a day, 10-19 cigarettes a day and more than 20 cigarettes a day (the last group referred to as "heavy smokers").
Results showed that, from the original 54,075 participants, 13,103 had died by the time of follow-up. But it was a significant finding that, of these, 45% of the heavy-smoking men had died during the 30 years, compared to just 18% of the never-smokers. Similarly, 33% of the heavy-smoking women had died, but only 13% of the never-smokers.
"These results show what a tremendous impact smoking has on mortality," says Professor Meyer. "We are talking about very high numbers of people."
A similar pattern was seen in the cardiovascular incidence rates reported in the follow-up questionnaire. In men the cumulative incidence of myocardial infarction was 10% in never-smokers and 21% in heavy smokers; in women 4% in never-smokers and 11% in heavy smokers. There were also strong associations found between smoking and stroke and diabetes.
"What these results show is the cumulative long-term association between smoking and death and cardiovascular risk," says Professor Meyer. "Around two-thirds of the middle-aged heavy-smoking men and half the heavy-smoking women had died or had a cardiovascular disease within the next 30 years. The incidence was much lower in never-smokers and reflects the tremendously adverse effect of smoking on health and longevity. The difference in outcome between the never-smokers and heavy smokers was substantial.
"This study underlines the public health messages about smoking. We have seen declines in the prevalence of smoking in developed countries, but challenges still remain. Certain population groups – young women, immigrant communities – still have high rates of smoking, and there's more to be done here."
1. Morbidity and mortality among smokers and non-smokers - 30 years follow-up of 54,000 middle-aged Norwegian women and men. Haakon Meyer, 7 May 2009, 15.30-16.30, Poster area.
2. EuroPRevent 2009 takes place in Stockholm, Sweden, on 6-9 May and is organised by The European Association for Cardiovascular Prevention and Rehabilitation (EACPR), a Registered Branch of the European Society of Cardiology.
3. Cardiovascular disease is the main cause of mortality in Europe, responsible for more than 2 million deaths per year. Many of these deaths could be prevented with the full adoption and application of prevention policies.
4. The full scientific programme of EuroPRevent 2009 is available at http://spo.escardio.org/Welcome.aspx?eevtid=30
5. More information on EuroPRevent 2009 is available from the ESC's press office at firstname.lastname@example.org OR 00 33 492 94 86 27.
ESC Press Office | EurekAlert!
When a fish becomes fluid
17.12.2018 | Institute of Science and Technology Austria
Some brain tumors may respond to immunotherapy, new study suggests
11.12.2018 | Columbia University Irving Medical Center
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Materials Sciences
19.12.2018 | Materials Sciences
19.12.2018 | Life Sciences